← Back to All Filings

Natera Officer Solomon Moshkevich Files Form 144 to Sell $1.23M in Stock Under 10b5-1 Plan

Low SignificanceNovember 2, 2026 at 4:46:47 PM EST

Natera, Inc.

$NTRA144CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Form 144 Notice of Proposed Sale of Securities

Company: Natera, Inc. ($NTRA) Insider: Solomon Moshkevich (Officer) Proposed Sale Date: 11/02/2026 Shares to Sell: 3,000 Common shares Estimated Value: $1,233,379.80 (~$411.13/share) Trading Plan: Rule 10b5-1 adopted on 11/26/2024 Broker: Morgan Stanley Smith Barney LLC

Comprehensive Analysis

Executive Summary

On November 2, 2026, Solomon Moshkevich, an Officer of Natera, Inc. ($NTRA), filed a Form 144 notice proposing the sale of 3,000 shares of common stock through Morgan Stanley Smith Barney LLC. The transaction carries an aggregate market value of approximately $1,233,379.80, implying an average price per share of $411.13.

Transaction Details

  • Securities to be Sold: 3,000 shares of Common Stock.
  • Origin of Shares: Acquired via the vesting of restricted stock awards between May 25, 2026, and October 26, 2026.
  • Rule 10b5-1 Plan: The filing indicates these sales are executed under a pre-established trading plan adopted on November 26, 2024.
  • Recent Past Sales (Past 3 Months): Moshkevich has conducted regular planned dispositions under this program, including:
    • 10/29/2026: 1,162 shares ($495,407.54)
    • 10/27/2026: 1,010 shares ($410,060.00)
    • 10/01/2026: 3,000 shares ($1,242,645.30)
    • 09/02/2026: 15,160 shares ($4,955,713.04)
    • 09/01/2026: 3,000 shares ($962,193.60)
    • 08/03/2026: 3,410 shares ($905,626.81 total across two trades)

Market Context & Significance

The trading significance is assessed as Low. While the aggregate market value of $1.23M is notable, the proposed disposition constitutes a tiny fraction of Natera's 144,144,170 shares outstanding and is executed pursuant to a longstanding Rule 10b5-1 plan adopted nearly two years prior.

Topics:#Natera#NTRA#Form144#InsiderTrading#SEC#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.